Skip to main content

Digital Surgery Technologies Market Segmentation & Forecast by 2030

 The global digital surgery technologies market was valued at $252.5 million in 2019 and is anticipated to reach $5,110.5 million by 2030, growing at a CAGR of 32.1% during the forecast period 2020-2030. The increasing complexities in clinical decision making, rising surgeon’s workload, and huge R&D investments are the major factors fueling the market growth. In addition to these factors, there are significant challenges and restraints, which are restricting market growth. These challenges include the surgeons’ reluctance toward the adoption of advanced technologies, such as AI and the privacy and security concerns related to healthcare data. Hence, it is anticipated that these trends will have a significant impact on the digital surgery technologies market in the next five years, and the market will grow multifold.

The global digital surgery technologies market consists of numerous large-scale as well as small-scale manufacturers and vendors. Presently, with the increasing adoption of AI in healthcare, the manufacturers in the market have an ample number of opportunities to expand their offerings and to establish a strong foothold in the market.

 

Market Segmentation

  • Product Type – Surgical Simulation, Surgical Navigation, Advanced Visualization Products, Surgical Data Science, and Surgical Planning
  • Technology Type- AI algorithms, Augmented Reality (AR)/ Virtual Reality (VR), Mixed Reality (MR), and Other Technologies


Regional Segmentation

  • North America- U.S. and Canada
  • Europe- Germany, U.K, Italy, Spain, France, and Rest-of-Europe
  • Asia-Pacific- Japan, China, South Korea, Australia, India and Rest-of-Asia-Pacific
  • Rest-of-the-World


Growth Drivers

  • Enhanced Accuracy, Promising Recovery from Pre-operative Surgical Planning
  • Results Based on Quantifiable Data
  • Increasing Interest of Technologist and Start-Ups

Market Challenges

  • Minimal Healthcare Budget Allocation for Digital Surgery Technologies
  • Impact of the Backlog in Elective Surgery Posing as a Major Challenge
  • Requirement of Additional Surgical Training
  • Requirement of Transparent Regulatory Guidelines, and Reimbursement Policies for AI/ML based medical device/Algorithm.


Market Opportunities

Promising growth opportunities for remote care, and telepresence.


Key Companies Profiled

Osso VR, Augmedics Ltd., Brainlab AG, Medtronic plc, Caresyntax, Inc., 3Dintegrated ApS, DASH Analytics, Novadaq Technologies, Inc., Fundamental VR, EchoPixel, Inc., Surgical Science Sweden AB., VirtaMed AG, Mimic Technologies, and Centerline Biomedical

 

Get Sample Report - https://bisresearch.com/requestsample?id=1013&type=download

Comments

Popular posts from this blog

Clinical Decision Support Systems (CDSS) Market registering a CAGR of 6.70% during the forecast period 2021-2030

The global market for clinical decision support systems (CDSS) registered the market value of $1,918.8 million in 2020 and is expected to reach $3,739.2 million by 2030, registering at a CAGR of 6.70% during the forecast period 2020-2030. The clinical decision support systems of the future are expected to be developed to leverage data to make observations which are not interpretable by humans. Healthcare IT systems in the future are expected to leverage cutting-edge technology as an enabler to make clinical care more streamlined and accurate. The technology is still in its nascent stage. One of the strong points of this technology is that it improves with time. Continuous input from clinicians, patients, and other stakeholders will be essential for correctly implementing the technology to enhance meaningful uses, reduce costs, and improve treatment outcomes. Key USPs of the Report Following are some of the key contents of the report: •     Industry Analysis    ...

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

  Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing   microbiome therapeutics market    is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...

Hyperspectral Imaging Market Projections , Upcoming Trends Focus on Long-Term Impact of Covid-19 and Forecast By 2027

  The global  hyperspectral imaging market  was estimated to be at $791.2 million in 2021, which is expected to grow with a CAGR of 13.17% and reach $1,640.3 million by 2027.The growth in the global hyperspectral imaging market is expected to be primarily driven by increased awareness of the technology in different sectors such as agriculture, healthcare, and mining. The hyperspectral imaging technology has great potential, and the market is anticipated to grow during the forecast period owing to the widespread applications of HSI, increasing investments for RD activities, increasing demand from military and defense sectors, increased food safety concerns, and increasing awareness regarding early diagnosis of diseases.   COVID-19 Impact and Post-COVID-19 Scenario The COVID-19 pandemic had a debilitating impact on the global ecosystem. The pandemic led to a shutdown of production facilities, which do not come under essential goods, which led to a negative impact on se...